Lara M. Fahmy
Yongsheng Chen
Stephanie Xuan3
E. Mark Haacke
Jiani Hu
Quan Jiang- 1Department of Psychiatry and Behavioral Neurosciences, Wayne State University, Detroit, MI, United States
- 2Department of Neurology, Wayne State University, Detroit, MI, United States
- 3Department of Radiology, Wayne State University, Detroit, MI, United States
- 4Department of Neurology, Henry Ford Health System, Detroit, MI, United States
Background: Recent emerging evidence has highlighted the potential critical role of cerebrospinal fluid (CSF) in cerebral waste clearance and immunomodulation. It is already very well-established that the central nervous system (CNS) is completely submerged in CSF on a macro-level; but to what extent is this true on a micro-level? Specifically, within the peri-neural and peri-vascular spaces within the CNS parenchyma. Therefore, the objective of this study was to use magnetic resonance imaging (MRI) to simultaneously map the presence of CSF within all peri-neural (cranial and spinal nerves) and peri-vascular spaces in vivo in humans. Four MRI protocols each with five participants were used to image the CSF in the brain and spinal cord. Our findings indicated that all CNS neuro- and vascular-communication channels are surrounded with CSF. In other words, all peri-neural spaces surrounding the cranial and spinal nerves as well as all peri-vascular spaces surrounding MRI-visible vasculature were filled with CSF. These findings suggest that anatomically, substance exchange between the brain parenchyma and outside tissues including lymphatic ones can only occur through CSF pathways and/or vascular pathways, warranting further investigation into its implications in cerebral waste clearance and immunity.
Introduction
The critical involvement of cerebrospinal fluid (CSF) in metabolic cerebral waste clearance (CWC) has gained a lot of momentum lately. Our traditional understanding of CSF circulation is that it is produced by the choroid plexus and circulates through the ventricles and subarachnoid spaces, exiting directly into the dural venous sinuses via arachnoid granulations/villi (1–5). Recent studies have expanded upon this traditional understanding and demonstrated that CSF penetrates and interacts with the brain parenchyma through a defined pathway with the purpose of CWC; this has been coined the glymphatic pathway (6). A significant portion of the subarachnoid CSF penetrates the brain parenchyma through para-arterial routes, facilitated by aquaporin-4 protein water channels (AQP4) on astrocytic end-feet (7–12). CSF then mixes with the interstitial fluid, and together, they are cleared debatably though para-venous routes with any associated solutes; once again, facilitated by AQP4 (8, 13–15). Dysfunctions of this glymphatic pathway have been associated with a broad range of neurological diseases including, but not limited to, Alzheimer's disease, stroke, traumatic brain injury, multiple sclerosis, diabetes, and chronic traumatic encephalopathy; begging the question of its involvement in virtually all neurodegenerative diseases (8–10, 12, 14, 16–19). Therefore, it has become apparent that gaining a complete and accurate understanding of CSF physiology is an essential prerequisite to understanding the pathophysiology underlying this broad range of neurological disease.
In light of the importance of CSF physiology, researchers have focused their attention on investigating CWC CSF outflow pathways, out of the central nervous system (CNS). The traditional outflow pathway via the arachnoid granulations/villi is becoming increasingly unpopular due to the lack of physiological evidence to support it (20, 21). This traditional pathway was primarily based on a study published over a 100 years ago, performed under non-physiologically high CSF pressure in human cadaver brain (22). More recently, the lymphatics have been identified as a major outflow pathway via peri-neural spaces (23, 24). Several studies have demonstrated the presence of CSF tracer within the sheaths surrounding cranial and spinal nerves; with the spotlight focused on the olfactory nerve (CN I) peri-neural space depositing into the nasal submucosa lymphatics (23–29). CSF within these peri-neural spaces exits the cranial cavity and vertebral column along the cranial and spinal nerves, respectively. At this point, CSF within the peri-neural spaces is proposed to be absorbed into the surrounding interstitial space/epidural tissue, and/or directly into the surrounding regional lymphatic vessels outside the CNS (26, 28, 30–34). Furthermore, the recently established meningeal lymphatic vessels are proposed to serve as another lymphatic-associated outflow pathway; However, the exact mechanism remains unclear (11, 35–37).
Although our understanding of CSF physiology remains relatively rudimentary and is still very much under investigation, one concept has become increasingly apparent: all CNS neuro- and vascular-communication channels are surrounded with CSF. It is already very well-established that the CNS is completely submerged in CSF on a macro-level; but now we know that this is true even on a micro-level, specifically within the peri-neural and peri-vascular spaces within the CNS parenchyma. Most studies have asynchronously investigated these spaces and these investigations have been mainly conducted in animals and human cadavers. Moreover, although CSF-filled peri-vascular spaces in several brain regions have been illustrated in several studies, to our knowledge, there is no systematic study focusing on whether all cerebral vasculature (with the exception of capillaries) are surrounded with CSF, and this can only be revealed using in vivo imaging methods. Therefore, the objective of this study was to use magnetic resonance imaging (MRI) to simultaneously map the presence of CSF within all peri-neural (cranial and spinal nerves) and peri-vascular spaces in vivo in humans.
Method
To prove the concept, we designed four types of experiments each with five healthy participants (ages 23–59 years; three males and two females). Each protocol was tailored to a specific area of investigation and anatomical structures, such as cranial nerves and their corresponding perineural spaces, cerebral vasculature and their corresponding perivascular spaces, and different segments of the spinal cord. The study was approved by local Institutional Review Board. Written consent was obtained prior to each MRI experiment. Various sequences were used to image CSF in the brain and spinal cord at 3T (Verio, Siemens Healthineers, Erlangen, Germany).
The first experiment employed a 3D T2-weighted (T2W) “Sampling Perfection with Application optimized Contrasts using different flip angle Evolution” (T2W-SPACE) sequence to image the CSF and cranial nerves with hyperintense CSF signal and hypointense signal for cranial nerves and blood vessels (38). This sequence yields a high nerve-to-CSF contrast and a high spatial resolution within a practical scanning time period. By optimizing timing parameters, uniform signal intensity of gray matter and white matter was acquired with repetition time (TR)/echo time (TE) = 1,000/132 ms. Imaging resolution was 0.5 × 0.5 × 0.8 mm3. With a parallel imaging accelerating factor of 2, the scanning time was 5 min for 114 axial slices covering the brain. All diameters were measured on the best shown slice using the standard software provided with the MRI scanner. We have reported the diameters as mean(±SE), as well as the diameter ratio of the cranial nerve diameter over the total diameter (cranial nerve diameter + corresponding peri-neural space diameter), for all 12 cranial nerves in healthy humans (Figures 1, 2).
Figure 1. CSF-filled peri-neural spaces surrounding the first five cranial nerves (CN I-CN V). (A) Olfactory nerves (CN I), (two original images, two corresponding magnified images and measurement location); (B) Optic nerves (CN II) (two original images, two corresponding magnified images and measurement location); (C) Oculomotor nerves (CN III) (two original images, two corresponding magnified images and measurement location); (D) Right trochlear nerve (CN IV) (two original images, two corresponding magnified images and measurement location); (E) Left CN IV (two original images, two corresponding magnified images and measurement location); and (F) Trigeminal nerves (CN V) (two original images, two corresponding magnified images and measurement location). Space within the yellow lines: respective nerve (hypointense signal). Space between the red and yellow lines: peri-neural space (hyperintense signal). Space between the blue lines: CN V (hypointense signal). White line: measurement location. All images were generated from the first experiment as described in the method section.
Figure 2. CSF-filled peri-neural spaces surrounding the cranial nerves 6–12 (CN VI-CN XII). (A) Abducens nerves (CN VI) (two original images, two corresponding magnified images and measurement location); (B) Facial nerves (CN VII) (two original images, two corresponding magnified images and measurement location); (C) Vestibulocochlear nerves (CN VIII) (two original images, two corresponding magnified images and measurement location); (D) Glossopharyngeal nerves (CN IX) (two original images, two corresponding magnified images and measurement location); (E) Vagus nerves (CN X) (two original images, two corresponding magnified images and measurement location); (F) Accessory nerves (CN IX) (two original images, two corresponding magnified images and measurement location); (G) Right hypoglossal nerve (CN XII) (two original images, two corresponding magnified images and measurement location); and (H) Left CN XII (two original images, two corresponding magnified images and measurement location). Space between the red and yellow lines: peri-neural space (hyperintense signal). White line: location to measure the diameters of cranial nerves and corresponding peri-neural spaces. All images were generated from the first experiment as described in the method section.
For the second experiment, in order to image CSF in peri-vascular spaces and to demonstrate that all MRI-visible cerebral blood vessels were surrounded by CSF, we used high-resolution “STrategically Acquired Gradient Echo” (STAGE) imaging to simultaneously obtain bright-blood and dark-blood images (39–41). The STAGE imaging included a proton density weighted (PDW) scan and a T1-weighted (T1W) scan. Both images were fully flow compensated with bright blood signal. By subtracting the PDW from the inverted T1W image, one could obtain a synthetic T2W dark-blood image (sT2W) presenting bright-CSF and uniform gray matter and white matter intensities. The high-resolution STAGE data were acquired in the sagittal plane with a scan matrix of 2,048 × 832 leading to a resolution of 0.1 × 0.2 × 2.0 mm3. Scan time was 17 min. The STAGE method simultaneously yielded naturally co-registered dark-blood (sT2W) and bright-blood (T1W) which were used to visualize the blood vessels and perivascular spaces in the order of 100 μm. In addition, to acquire a pure CSF image with suppressed blood signals, we used a 3D turbo-spin echo (TSE) sequence with TR/TE = 2,000/345 ms and an isotropic voxel size of 0.5 mm. With such a long echo time, the images were heavily T2-weighted such that all tissues other than CSF (very long T2) were suppressed. Given the long TR/TE and high-resolution 3D sampling scheme, the sequence took half an hour covering the central half of the brain in the sagittal plane.
The third experiment was performed on the cervical spinal cord at the C4/C5 level. A 2D T2* weighted spoiled gradient echo sequence (Multiple Echo Data Image Combination, MEDIC) was used to acquire images with hyperintense CSF and blood vessels, and hypointense nerves. This sequence is one of the clinical sequences for cervical protocol. Imaging parameters were: TR = 587 ms, TE = 17 ms, flip angle = 30°, in-plane resolution = 0.5 × 0.5 mm2, slice thickness = 3 mm, scanning time = 3 min.
The fourth and final experiment was for imaging the lumbar spinal nerves at L3/L4 level. A regular T2W-TSE sequence was used with the following imaging parameters: TR = 5,490 ms, TE = 87 ms, in-plane resolution = 0.6 × 0.6 mm2, slice thickness = 4 mm, scanning time = 2 min. This sequence, with sub-millimeter in-plane resolution, provided high nerve-to-CSF contrast. The 12 pairs of cranial nerves and spinal nerves were labeled by experienced neuroradiologist on images from the first, third and fourth experiments.
Results
All MRI data were first visually evaluated to label nerves and vessels on representative images. Representative images of the first experiment are shown in Figures 1, 2. Images in Figure 3 are from the third and fourth experiments. The results of the second experiment are shown in Figure 4.
Figure 3. CSF-filled peri-neural spaces surrounding spinal nerves. (A) Cervical spinal nerves (brachial plexus). Cervical nerves four are pointed with red arrows (hypointense signal), and the space surrounding the nerves is the CSF-filled peri-neural space (hyperintense signal). Multiple lymph nodes are detected from MRI (white arrowhead). (B) Lumbar spinal nerves (red arrows, hypointense signal) surrounded with CSF-filled peri-neural space (hyperintense signal). Images were generated from the third and the fourth experiments as described in the method section.
Figure 4. Illustration showing that all MRI-visible vasculature were surrounded by CSF. (A) sT2W image with bright CSF and dark blood; (B) T1W with bright blood signal but dark CSF signal; (C) CSF-only images, acquired by T2-TSE sequence with TE = 345 ms at 3T; (D) a 3D rendering of the CSF-only images. (A) and (B) were results from the high-resolution STAGE scans. The enlarged image in (C) shows several MRI-visible vasculature (dark curves) surrounded by bright CSF. Images were generated from the second experiment as described in the method section.
The CNS Neuro-Communication Channels Are Surrounded With CSF
The CNS neuro-communication channels consist of 12 pairs of cranial nerves and 31 pairs of spinal nerves. Images from the first experiment were used to visualize all 12 pairs of the cranial nerves (Figures 1, 2). As illustrated, the cranial nerves were hypointense, while the peri-neural spaces surrounding the cranial nerves were hyperintense, indicating the presence of CSF within these spaces. We qualitatively observed that the peri-neural spaces had a slightly higher signal intensity than other CSF compartments. This is consistent with an array of previous studies which has already taken a closer look at the peri-neural spaces and its fluid contents, indicating that the peri-neural spaces are filled with a mixture of CSF and interstitial fluid (ISF) (24, 26–29, 42–51).
Figure 1A shows an axial view of a pair of hypointense CN I, encased in hyperintense CSF-filled perineural space, on either side of a boney projection inferior to the frontal lobe, the crista galli. The mean diameter for CN I was 4.3(±0.8) mm and the mean total diameter (CN I + corresponding peri-neural space) was 6.0(±0.6) mm, with a diameter ratio (CN I diameter over total diameter) of 0.7 (Table 1). Figure 1B shows an axial view of a pair of hypointense optic nerves (CN II), encased in hyperintense CSF-filled perineural space, emerging from the optic chiasm. The mean diameter for CN II was 3.2(±0.5) mm and the mean total diameter (CN II + corresponding peri-neural space) was 5.0(±0.5) mm, with a diameter ratio (CN II diameter over total diameter) of 0.6 (Table 1). Figure 1C shows an axial view of a pair of hypointense oculomotor nerves (CN III), surrounded with hyperintense CSF-filled perineural space, emerging from the midbrain. The mean diameter for CN III was 1.9(±0.5) mm and the mean total diameter (CN III + corresponding peri-neural space) was 2.6(±0.4) mm, with a diameter ratio (CN III diameter over total diameter) of 0.7 (Table 1). Figures 1D,E show axial views of a pair of hypointense trochlear nerves (CN IV), surrounded with hyperintense CSF-filled perineural space, emerging from the midbrain. The mean diameter for CN IV was 0.9(±0.3) mm and the mean total diameter (CN IV + corresponding peri-neural space) was 1.4(±0.5) mm, with a diameter ratio (CN IV diameter over total diameter) of 0.6 (Table 1). Figure 1F shows an axial view of a pair of hypointense trigeminal nerves (CN V), encased in hyperintense CSF-filled perineural space, emerging from the pons. The mean diameter for CN V was 4.6(±0.4) mm and the mean total diameter (CN V + corresponding peri-neural space) was 5.7(±0.4) mm, with a diameter ratio (CN V diameter over total diameter) of 0.8 (Table 1).
Table 1. Diameter measurements and diameter ratios for all 12 cranial nerves.
Figure 2A shows an axial view of a pair of hypointense abducens nerves (CN VI), surrounded with hyperintense CSF-filled perineural space, emerging from the pons. The mean diameter for CN VI was 1.1(±0.1) mm and the mean total diameter (CN VI + corresponding peri-neural space) was 1.9(±0.2) mm, with a diameter ratio (CN VI diameter over total diameter) of 0.6 (Table 1). Figure 2B shows an axial view of a pair of hypointense facial nerves (CN VII), surrounded with hyperintense CSF-filled perineural space, emerging from the pons. The mean diameter for CN VII was 1.0(±0.2) mm and the mean total diameter (CN VII + corresponding peri-neural space) was 1.6(±0.1) mm, with a diameter ratio (CN VII diameter over total diameter) of 0.6 (Table 1). Figure 2C shows an axial view of a pair of hypointense vestibulocochlear nerves (CN VIII), surrounded with hyperintense CSF-filled perineural space, emerging from the pons. The mean diameter for CN VIII was 1.1(±0.3) mm and the mean total diameter (CN VIII + corresponding peri-neural space) was 1.7(±0.2) mm, with a diameter ratio (CN VIII diameter over total diameter) of 0.6 (Table 1). Figure 2D shows an axial view of a pair of hypointense glossopharyngeal nerves (CN IX), surrounded with hyperintense CSF-filled perineural space, emerging from the medulla. The mean diameter for CN IX was 1.2(±0.1) mm and the mean total diameter (CN IX + corresponding peri-neural space) was 1.9(±0.3) mm, with a diameter ratio (CN IX diameter over total diameter) of 0.6 (Table 1). Figure 2E shows an axial view of a pair of hypointense vagus nerves (CN X), encased in hyperintense CSF-filled perineural space, emerging from the medulla. The mean diameter for CN X was 1.4(±0.2) mm and the mean total diameter (CN X + corresponding peri-neural space) was 1.9(±0.3) mm, with a diameter ratio (CN X diameter over total diameter) of 0.7 (Table 1). Figure 2F shows an axial view of a pair of hypointense accessory nerves (CN IX), encased in hyperintense CSF-filled perineural space, emerging from the medulla. The mean diameter for CN XI was 1.1(±0.1) mm and the mean total diameter (CN XI + corresponding peri-neural space) was 1.7(±0.2) mm, with a diameter ratio (CN XI diameter over total diameter) of 0.6 (Table 1). Figures 2G,H show axial views of a pair of hypointense hypoglossal nerves (CN XII), encased in hyperintense CSF-filled perineural space, emerging from the medulla. The mean diameter for CN XII was 0.9(±0.2) mm and the mean total diameter (CN XII + corresponding peri-neural space) was 1.3(±0.1) mm, with a diameter ratio (CN XII diameter over total diameter) of 0.7 (Table 1).
The spinal nerves were visualized on the images from the third and fourth experiments (Figure 3). Similarly, the spinal nerves were hypointense, while the peri-neural spaces surrounding the spinal nerves were hyperintense, indicating the presence of CSF. Figure 3A shows an axial view of a pair of hypointense cervical spinal nerves emerging from the spinal cord at the level of C4/C5, surrounded with hyperintense CSF-filled perineural space. Figure 3B shows an axial view of a pair of hypointense lumbar spinal nerves emerging from the spinal cord at the level of L3/L4, encased in hyperintense CSF-filled perineural space.
The CNS Vascular-Communication Channels Are Surrounded With CSF
The high-resolution (in the order of 100 μm) sT2W (Figure 4A, bright CSF and dark blood) and T1W (Figure 4B, bright blood and dark CSF) derived from STAGE imaging demonstrated that all MRI-visible vasculature were surrounded with CSF. By comparing these two images, we found that all MRI-visible vasculature were indeed surrounded by CSF. Moreover, in order to further confirm these findings, we used a T2W-TSE image acquired with a very long echo time (TE = 345 ms at 3T) to generate “pure” CSF images, with bright CSF and dark blood (Figures 4C,D). Once again, all MRI-visible vasculature were indeed surrounded with CSF.
Discussion
To our knowledge, this is the first study to simultaneously and systematically verify that all 12 pairs of cranial nerves, all MRI-visible vasculature and spinal nerves are surrounded with CSF in vivo in humans; as opposed to previous studies that have asynchronously investigated this, mainly in animals and human cadavers. Our findings indicate that all brain parenchyma and spinal cord communication channels, both neuro- and vascular-communication channels, are encased in CSF. The diameter ratios, nerve diameter over total diameter (nerve diameter + corresponding peri-neural space), ranged from 0.6–0.8. It logically follows that CSF must play a critical role in substance exchange between the brain parenchyma/spinal cord and its communication channels as well as its surrounding environment/tissue—a role that has been historically underestimated and understudied. Our findings are consistent with previous literature that have asynchronously investigated CSF-filled peri-neural spaces, mostly in the context of CWC lymphatic-associated CSF outflow pathways, as well as peri-vascular spaces (2, 7, 8, 52, 53).
Our findings indicated that CN I is surrounded with a CSF-filled peri-neural space, with a diameter ratio of 0.7. This is consistent with several studies that have focused on investigating the peri-neural spaces surrounding CN I. In 1958, Svane-Knudsen et al. observed that an iron solution injected in the CSF of guinea pigs made its way to the peri-neural spaces of CN I and the nasal interstitium (43). Bradbury et al. found that a radio-labeled intra-parenchymal tracer injection in rabbits drained via peri-vascular spaces and peri-neural spaces surrounding the CN I, allowing passage into the nasal submucosa and lymphatics (45). Similar findings were observed in a study conducted by Pile-Spellman et al. in cats and rabbits, where radiolabeled colloid tracer injected in the ventricles made its way into the nasal submucosa and eventually into the cervical lymph nodes (46). A series of experiments conducted by Mollanji et al. identified the peri-neural spaces surrounding CNI as a major lymphatic-associated CSF outflow pathway in sheep; and demonstrated that blockage of the cribriform plate increased intracranial pressure and CSF outflow resistance, and decreased CSF transport (48–50). Moreover, in a series of experiments conducted by Johnston et al. in sheep, pigs, rabbits, mice, rats, monkeys and human cadavers, demonstrated that a silicone compound CSF tracer made its way into an extensive network of lymphatic vessels present in the nasal submucosa via peri-neural spaces surrounding CN I (28). More recent studies have been consistently confirming these findings (24, 29, 51). Furthermore, and interestingly, Czerniawska et al. found evidence of retrograde transport of a gold tracer injected in rabbit nasal mucosa back into the CSF (44). However, to the best of our knowledge, none of these studies have reported a quantitative diameter ratio for CN I.
Our findings also indicated that, in addition to CN I, the other 11 cranial nerves are also surrounded with CSF-filled peri-neural spaces, with diameter ratios ranging from 0.6–0.8. The peri-neural spaces of other cranial nerves have been studied to a lesser extent. In 1972, Arnold et al., using mice, rats, guinea pigs and rabbits, reported that the peri-neural spaces along CNV III played a role in CSF drainage into the perilymphatic spaces of the inner ear, following ink and thorotrast CSF cisterna magna tracer injection. Moreover, Kida et al. observed CSF tracer deposition along the peri-neural spaces of CN II, in addition to CN I and CN III, following an injection of india ink CSF cisterna magna tracer in rats (26). Similar findings (for CN I, CN II and CNV III) were observed in an experiment conducted by Boulton et al. in sheep injected with radiolabeled CSF tracer (47). Furthermore, Zakharov et al. identified the peri-neural spaces along CN V, CNV II, CN IX, CN X, CN XII and spinal nerves as contributors to the lymphatic-associated CSF outflow pathway in sheep, following a silicone compound CSF cisterna magna injection (27). A couple of other studies have also identified the spinal nerves as contributors to the lymphatic-associated CSF outflow pathway (29, 42). More recently, Ma et al. identified the peri-neural spaces along CN XI, in addition to CN I, CN II, CN V, CN VII, CN IX and CN X, as contributors to the lymphatic-associated CSF outflow pathway in rats, following a near-infrared CSF lateral ventricle injection (24). To our knowledge, the peri-neural spaces along the CN III, the CN IV and CN VI have not been previously identified as CSF-filled and potentially contributing to lymphatic-associated CSF outflow pathways. Moreover, to our knowledge, none of these previous studies have reported quantitative diameter ratios for the cranial nerves. Unlike the diameter ratios of peri-vascular spaces, which have been previously reported mainly in animal studies (8), the diameter ratios of peri-neural spaces have simply passed under the radar. The utility of these diameter ratios can be investigated in neurodegenerative diseases such as Alzheimer's disease. In other words, future studies can focus on investigating the association between these diameter ratio changes and neurodegenerative diseases; since enlarged peri-vascular spaces have been reported with neurodegenerative diseases (17, 54, 55).
Our findings drive home the point that CSF lays between every cranial/spinal nerve and its surroundings (i.e., brain parenchyma and/or peripheral lymphatics), in the peri-neural spaces. Therefore, CSF must play a critical role in regulating the communication between the cranial nerves and their surroundings. One such type of communication regulation is with the lymphatic system. In fact, the interaction of CSF with the lymphatic system is only beginning to be understood. There is a growing body of evidence to suggest that CSF tracer eventually makes it into the deep cervical lymph nodes (24, 36, 37). Historically, the CNS is considered an immune-privileged site and therefore it was believed that antigens in the CNS did not communicate with the immune system (56–58). However, about 14–47% of radiolabeled tracers make their way into the lymphatic system, following CSF or intra-parenchymal injections (59). Therefore, antigens are transported to the immune system and can induce an immune response (56–58). Louveau et al. further demonstrated a decrease in the inflammatory response of brain-reactive T cells in a multiple sclerosis mouse model, following meningeal lymphatic vessel ablation (37). Anatomically-speaking, there is no direct interaction between the lymphatic system and CNS, and any interaction can only be accomplished through the CSF. Therefore, this begs the question of the role of CSF in immunomodulation, and together with our findings, the magnitude of this role.
Our findings also drive home the point that all MRI-visible vasculature is surrounded with CSF-filled peri-vascular spaces. Therefore, CSF must play a critical role in regulating the communication between the blood and the brain parenchyma, as well as CWC at large. In 1985, Rennels et al. introduced the idea of a fluid circulation system throughout the CNS via peri-vascular spaces (7). But it was not until 2012 that Iliff et al. solidified our understanding of this CSF circulation system via peri-vascular spaces within the brain parenchyma (labeled the glymphatic pathway); and demonstrated its critical role in amyloid beta (Aβ) clearance (8). Further investigations have indicated that the diameter ratios between the peri-arterial spaces and their corresponding arterial vessels are larger than the diameter ratios between the peri-venous spaces and their corresponding venous spaces (60). As mentioned earlier, dysfunctions of this glymphatic pathway have been associated with a broad range of neurological diseases including, but not limited to, Alzheimer's disease, stroke, traumatic brain injury, multiple sclerosis, diabetes, and chronic traumatic encephalopathy; begging the question of its involvement in virtually all neurodegenerative diseases (8–10, 12, 14, 16–19). Therefore, disruptions to CWC can either initiate or/and aggravate the pathophysiology of an array of neurological diseases.
Starting 6 years ago, gadolinium-based contrast agent (GCA) residual deposition in the brain parenchyma with chronic administration has been documented (61, 62). GCA is a widely used contrast agent in clinical MRI. It does not cross the BBB and is renally eliminated from the human body; and thus, considered safe for clinical use. Therefore, the residual deposition of IV-administered GCA in individuals with an intact BBB and normal renal function raised a lot of questions. How does the IV-administered GCA enter and deposit in the brain parenchyma? Currently, the mainstream theory is through the CSF via the glymphatic pathway. Based on several studies, it is hypothesized that the IV-administered GCA enters the CSF compartment through the choroid plexus, cranial nerve endings and/or peri-vascular spaces surrounding vessels; from here it re-circulates and enters the brain parenchyma via peri-arterial routes—a portion gets deposited in the brain parenchyma, while the remaining portion gets carried away via peri-venous routes, eventually draining into the lymphatics (63–66). CSF involvement was further confirmed by Öner et al. in a study investigating individuals with chronic intra-thecal administration of GCA who had never undergone IV-administration of GCA; similar GCA deposition patterns were observed (67). GCA deposition via CSF is an example of how CSF-filled peri-vascular and peri-neural spaces play a critical and major role in substance deposition and re-circulation. Long-term effects of GCA deposition are unknown and require further investigation.
There are several major strengths to our study. First, to our knowledge, it is the first study to systematically and simultaneously verify that CSF surrounds all cranial (including CN III, CN IV and CN VI which have not been previously investigated), all MRI-visible vasculature and spinal nerves. Second, our study was performed in vivo in humans. Third, our study utilized MRI which is minimally invasive and therefore caused minimal disruption to the biological system. In the past, most MRI studies of the peri-neural and peri-vascular spaces have been mainly conducted in animals (64, 68).
On the other hand, the major limitation of our study is that we did not investigate the underlying mechanisms of how CSF made it into or out of these peri-vascular and peri-neural spaces. Although this has been a topic-of-interest as of late, and several strides have been made to address this topic, the latest of which has been the establishment of the glymphatic pathway, the CSF efflux mechanisms remain unclear. One current question of interest is: “What is the underlying pathway/mechanism by which CSF drains into the meningeal lymphatics, and how is this pathway/mechanism related to CSF-filled peri-vascular and peri-neural spaces?” Another major limitation is that we did not investigate if and how CSF communicates with the CNS neuro- and vascular-communication channels themselves (i.e., the vasculature and nerves that it surrounds), nor a quantitative morphometric measurement of the arterial and venous blood vessels and their corresponding peri-vascular spaces. There is growing evidence to suggest that CSF in peri-vascular spaces might be involved in the direct transport of cerebral waste into the parenchymal vasculature, perhaps through transcellular mechanisms (29, 69, 70). However, given the pathophysiological variations, the systematic measurement of blood vessels and their corresponding peri-vascular space across multiple regions of the brain are complex and also warrant further investigation. Another major limitation is our small sample size of healthy human volunteers. Therefore, future investigations with larger sample sizes are warranted; perhaps even these investigations should be extended to beyond healthy individuals, i.e., patients with neurogenerative diseases such as Alzheimer's disease. Finally, the measured size of cranial nerves and their relative perineural spaces may suffer from partial volume effects which is a common issue with MRI.
In conclusion, our findings indicate that all CNS neuro- and vascular-communication channels are surrounded with CSF. In other words, all peri-neural spaces surrounding the cranial and spinal nerves as well as all peri-vascular spaces surrounding MRI-visible vasculature were filled with CSF. These findings highlight the extent to which CSF infiltrates the parenchyma and its importance, therefore, warranting further investigation into its potential implications.
Data Availability Statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Ethics Statement
The studies involving human participants were reviewed and approved by Wayne State University Institutional Review Board. The patients/participants provided their written informed consent to participate in this study.
Author Contributions
LF participated in conceptualization, data acquisition, data analysis, manuscript writing, and manuscript editing. YC participated in conceptualization, investigation, data acquisition, data analysis, manuscript writing, and manuscript editing. SX participated in data acquisition, data analysis, and manuscript editing. EH participated in methodology, data analysis, and manuscript editing. JH participated in conceptualization, methodology, data analysis, and manuscript editing. QJ participated in conceptualization, methodology, data analysis, and manuscript editing. All authors contributed to the article and approved the submitted version.
Funding
This work was supported by the following NIH grants: R01-NS108491, RF1-AG057494, and R01-NS108463.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1. McAllister JP II, Chovan P. Neonatal hydrocephalus. Mechanisms and consequences. Neurosurg Clin N Am. (1998) 9:73–93. doi: 10.1016/S1042-3680(18)30281-X
2. Pollay M. The function and structure of the cerebrospinal fluid outflow system. Cerebrospinal Fluid Res. (2010) 7:9. doi: 10.1186/1743-8454-7-9
3. Wright BL, Lai JT, Sinclair AJ. Cerebrospinal fluid and lumbar puncture: a practical review. J Neurol. (2012) 259:1530–45. doi: 10.1007/s00415-012-6413-x
4. Bakker EN, Bacskai BJ, Arbel-Ornath M, Aldea R, Bedussi B, Morris AW, et al. Lymphatic clearance of the brain: perivascular, paravascular and significance for neurodegenerative diseases. Cell Mol Neurobiol. (2016) 36:181–94. doi: 10.1007/s10571-015-0273-8
6. Wang JJ, Iliff M, Liao Y, Chen MJ, Shinseki MS, Venkataraman A, et al. Cognitive deficits and delayed neuronal loss in a mouse model of multiple microinfarcts. J Neurosci. (2012) 32:17948–60. doi: 10.1523/JNEUROSCI.1860-12.2012
7. Rennels ML, Gregory TF, Blaumanis OR, Fujimoto K, Grady PA. Evidence for a ‘paravascular’ fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space. Brain Res. (1985) 326:47–63. doi: 10.1016/0006-8993(85)91383-6
8. Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med. (2012) 4:147ra111. doi: 10.1126/scitranslmed.3003748
9. Rangroo Thrane AS, Thrane V, Plog BA, Thiyagarajan M, Iliff JJ, Deane R, et al. Paravascular microcirculation facilitates rapid lipid transport and astrocyte signaling in the brain. Sci Rep. (2013) 3:2582. doi: 10.1038/srep02582
10. Jessen NA, Munk AS, Lundgaard I, Nedergaard M. The glymphatic system: a beginner's guide. Neurochem Res. (2015) 40:2583–99. doi: 10.1007/s11064-015-1581-6
11. Louveau A, Smirnov I, Keyes TJ, Eccles JD, Rouhani SJ, Peske JD, et al. Structural and functional features of central nervous system lymphatic vessels. Nature. (2015) 523:337–41. doi: 10.1038/nature14432
12. Plog BA, Dashnaw ML, Hitomi E, Peng W, Liao Y, Lou N, et al. Biomarkers of traumatic injury are transported from brain to blood via the glymphatic system. J Neurosci. (2015) 35:518–26. doi: 10.1523/JNEUROSCI.3742-14.2015
13. Carare RO, Bernardes-Silva M, Newman TA, Page AM, Nicoll JA, Perry VH, et al. Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology. Neuropathol Appl Neurobiol. (2008) 34:131–44. doi: 10.1111/j.1365-2990.2007.00926.x
14. Arbel-Ornath M, Hudry E, Eikermann-Haerter K, Hou S, Gregory JL, Zhao L, et al. Interstitial fluid drainage is impaired in ischemic stroke and Alzheimer's disease mouse models. Acta Neuropathol. (2013) 126:353–64. doi: 10.1007/s00401-013-1145-2
15. Albargothy NJ, Johnston DA, MacGregor-Sharp M, Weller RO, Verma A, Hawkes CA, et al. Convective influx/glymphatic system: tracers injected into the CSF enter and leave the brain along separate periarterial basement membrane pathways. Acta Neuropathol. (2018) 136:139–52. doi: 10.1007/s00401-018-1862-7
16. Louveau A, Da Mesquita S, Kipnis J. Lymphatics in neurological disorders: a neuro-lympho-vascular component of multiple sclerosis and Alzheimer's disease? Neuron. (2016) 91:957–73. doi: 10.1016/j.neuron.2016.08.027
17. Jiang Q, Zhang L, Ding G, Davoodi-Bojd E, Li Q, Li L, et al. Impairment of the glymphatic system after diabetes. J Cereb Blood Flow Metab. (2017) 37:1326–37. doi: 10.1177/0271678X16654702
18. Mestre H, Tithof J, Du T, Song W, Peng W, Sweeney AM, et al. Flow of cerebrospinal fluid is driven by arterial pulsations and is reduced in hypertension. Nat Commun. (2018) 9:4878. doi: 10.1038/s41467-018-07318-3
19. Mestre H, Du T, Sweeney AM, Liu G, Samson AJ, Peng W, et al. Cerebrospinal fluid influx drives acute ischemic tissue swelling. Science. (2020) 367:6483. doi: 10.1126/science.aax7171
20. McComb JG. Recent research into the nature of cerebrospinal fluid formation and absorption. J Neurosurg. (1983) 59:369–83. doi: 10.3171/jns.1983.59.3.0369
21. Zakharov A, Papaiconomou C, Johnston M. Lymphatic vessels gain access to cerebrospinal fluid through unique association with olfactory nerves. Lymphat Res Biol. (2004) 2:139–46. doi: 10.1089/lrb.2004.2.139
22. Weed LH. Studies on Cerebro-Spinal Fluid. No. III : The pathways of escape from the Subarachnoid Spaces with particular reference to the Arachnoid Villi. J Med Res. (1914) 31:51–91.
23. Koh L, Zakharov A, Johnston M. Integration of the subarachnoid space and lymphatics: is it time to embrace a new concept of cerebrospinal fluid absorption? Cerebrospinal Fluid Res. (2005) 2:6. doi: 10.1186/1743-8454-2-6
24. Ma BV, Ineichen Q, Detmar M, Proulx ST. Outflow of cerebrospinal fluid is predominantly through lymphatic vessels and is reduced in aged mice. Nat Commun. (2017) 8:1434. doi: 10.1038/s41467-017-01484-6
25. Bradbury MW, Westrop RJ. Factors influencing exit of substances from cerebrospinal fluid into deep cervical lymph of the rabbit. J Physiol. (1983) 339:519–34. doi: 10.1113/jphysiol.1983.sp014731
26. Kida S, Pantazis A, Weller RO. CSF drains directly from the subarachnoid space into nasal lymphatics in the rat. Anatomy, histology and immunological significance. Neuropathol Appl Neurobiol. (1993) 19:480–8. doi: 10.1111/j.1365-2990.1993.tb00476.x
27. Zakharov A, Papaiconomou C, Djenic J, Midha R, Johnston M. Lymphatic cerebrospinal fluid absorption pathways in neonatal sheep revealed by subarachnoid injection of Microfil. Neuropathol Appl Neurobiol. (2003) 29:563–73. doi: 10.1046/j.0305-1846.2003.00508.x
28. Johnston M, Zakharov A, Papaiconomou C, Salmasi G, Armstrong D. Evidence of connections between cerebrospinal fluid and nasal lymphatic vessels in humans, non-human primates and other mammalian species. Cerebrospinal Fluid Res. (2004) 1:2. doi: 10.1186/1743-8454-1-2
29. Krishnamurthy S, Li J, Shen Y, Duncan TM, Jenrow KA, Haacke EM. Normal macromolecular clearance out of the ventricles is delayed in hydrocephalus. Brain Res. (2018) 1678:337–55. doi: 10.1016/j.brainres.2017.10.013
30. Shen JY, Kelly DE, Hyman S, McComb JG. Intraorbital cerebrospinal fluid outflow and the posterior uveal compartment of the hamster eye. Cell Tissue Res. (1985) 240:77–87. doi: 10.1007/BF00217560
31. Erlich SS, McComb JG, Hyman S, Weiss MH. Ultrastructural morphology of the olfactory pathway for cerebrospinal fluid drainage in the rabbit. J Neurosurg. (1986) 64:466–73. doi: 10.3171/jns.1986.64.3.0466
32. Erlich SS, McComb JG, Hyman S, Weiss MH. Ultrastructure of the orbital pathway for cerebrospinal fluid drainage in rabbits. J Neurosurg. (1989) 70:926–31. doi: 10.3171/jns.1989.70.6.0926
33. Zakharov A, Papaiconomou C, Koh L, Djenic J, Bozanovic-Sosic R, Johnston M. Integrating the roles of extracranial lymphatics and intracranial veins in cerebrospinal fluid absorption in sheep. Microvasc Res. (2004) 67:96–104. doi: 10.1016/j.mvr.2003.08.004
34. Ludemann W, Berens von Rautenfeld D, Samii M, Brinker T. Ultrastructure of the cerebrospinal fluid outflow along the optic nerve into the lymphatic system. Childs Nerv Syst. (2005) 21:96–103. doi: 10.1007/s00381-004-1040-1
35. Aspelund A, Antila S, Proulx ST, Karlsen TV, Karaman S, Detmar M, et al. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J Exp Med. (2015) 212:991–9. doi: 10.1084/jem.20142290
36. Da Mesquita S, Louveau A, Vaccari A, Smirnov I, Cornelison RC, Kingsmore KM, et al. Functional aspects of meningeal lymphatics in ageing and Alzheimer's disease. Nature. (2018) 560:185–91. doi: 10.1038/s41586-018-0368-8
37. Louveau A, Herz J, Alme MN, Salvador AF, Dong MQ, Viar KE, et al. CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature. Nat Neurosci. (2018) 21:1380–91. doi: 10.1038/s41593-018-0227-9
38. Mugler JP III, Bao S, Mulkern RV, Guttmann CR, Robertson RL, Jolesz FA, et al. Optimized single-slab three-dimensional spin-echo MR imaging of the brain. Radiology. (2000) 216:891–9. doi: 10.1148/radiology.216.3.r00au46891
39. Chen Y, Liu S, Wang Y, Kang Y, Haacke EM. STrategically Acquired Gradient Echo (STAGE) imaging, part I: Creating enhanced T1 contrast and standardized susceptibility weighted imaging and quantitative susceptibility mapping. Magn Reson Imaging. (2018) 46:130–9. doi: 10.1016/j.mri.2017.10.005
40. Wang Y, Chen Y, Wu D, Wang Y, Sethi SK, Yang G, et al. STrategically Acquired Gradient Echo (STAGE) imaging, part II: Correcting for RF inhomogeneities in estimating T1 and proton density. Magn Reson Imaging. (2018) 46:140–50. doi: 10.1016/j.mri.2017.10.006
41. Haacke EM, Chen Y, Utriainen D, Wu B, Wang Y, Xia S, et al. STrategically Acquired Gradient Echo (STAGE) imaging, part III: Technical advances and clinical applications of a rapid multi-contrast multi-parametric brain imaging method. Magn Reson Imaging. (2020) 65:15–26. doi: 10.1016/j.mri.2019.09.006
42. Brierley JB, Field EJ. The connexions of the spinal sub-arachnoid space with the lymphatic system. J Anat. (1948) 82:153–66.
43. Svane-Knudsen V. Resorption of the cerebro-spinal fluid in guinea-pig; an experimental study. Acta Otolaryngol. (1958) 49:240–51. doi: 10.3109/00016485809134752
44. Czerniawska A. Experimental investigations on the penetration of 198Au from nasal mucous membrane into cerebrospinal fluid. Acta Otolaryngol. (1970) 70:58–61. doi: 10.3109/00016487009181859
45. Bradbury MW, Cserr HF, Westrop RJ. Drainage of cerebral interstitial fluid into deep cervical lymph of the rabbit. Am J Physiol. (1981) 240:F329–36. doi: 10.1152/ajprenal.1981.240.4.F329
46. Pile-Spellman JM, McKusick KA, Strauss HW, Cooney J, Taveras JM. Experimental in vivo imaging of the cranial perineural lymphatic pathway. AJNR Am J Neuroradiol. (1984) 5:539–45.
47. Boulton M, Young A, Hay J, Armstrong D, Flessner M, Schwartz M. Drainage of CSF through lymphatic pathways and arachnoid villi in sheep: measurement of 125I-albumin clearance. Neuropathol Appl Neurobiol. (1996) 22:325–33. doi: 10.1111/j.1365-2990.1996.tb01111.x
48. Mollanji R, Bozanovic-Sosic R, Silver I, Li B, Kim C, Midha R. Intracranial pressure accommodation is impaired by blocking pathways leading to extracranial lymphatics. Am J Physiol Regul Integr Comp Physiol. (2001) 280:R1573–81. doi: 10.1152/ajpregu.2001.280.5.R1573
49. Mollanji R, Papaiconomou C, Boulton M, Midha R, Johnston M. Comparison of cerebrospinal fluid transport in fetal and adult sheep. Am J Physiol Regul Integr Comp Physiol. (2001) 281:R1215–23. doi: 10.1152/ajpregu.2001.281.4.R1215
50. Mollanji R, Bozanovic-Sosic R, Zakharov A, Makarian L, Johnston MG. Blocking cerebrospinal fluid absorption through the cribriform plate increases resting intracranial pressure. Am J Physiol Regul Integr Comp Physiol. (2002) 282:R1593–9. doi: 10.1152/ajpregu.00695.2001
51. Liu H, Ni Z, Chen Y, Wang D, Qi Y, Zhang Q, et al. Olfactory route for cerebrospinal fluid drainage into the cervical lymphatic system in a rabbit experimental model. Neural Regen Res. (2012) 7:766–71. doi: 10.3969/j.issn.1673-5374.2012.10.009
52. Sakka L, Coll G, Chazal J. Anatomy and physiology of cerebrospinal fluid. Eur Ann Otorhinolaryngol Head Neck Dis. (2011) 128:309–16. doi: 10.1016/j.anorl.2011.03.002
53. Chen L, Elias G, Yostos MP, Stimec B, Fasel J, Murphy K. Pathways of cerebrospinal fluid outflow: a deeper understanding of resorption. Neuroradiology. (2015) 57:139–47. doi: 10.1007/s00234-014-1461-9
54. Doubal FN, MacLullich AM, Ferguson KJ, Dennis MS, Wardlaw JM. Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease. Stroke. (2010) 41:450–4. doi: 10.1161/STROKEAHA.109.564914
55. Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol. (2013) 12:483–97. doi: 10.1016/S1474-4422(13)70060-7
56. Ferguson TA, Griffith TS. A vision of cell death: insights into immune privilege. Immunol Rev. (1997) 156:167–84. doi: 10.1111/j.1600-065X.1997.tb00967.x
57. Streilein JW, Ksander BR, Taylor AW. Immune deviation in relation to ocular immune privilege. J Immunol. (1997) 158:3557–60.
58. Streilein JW, Takeuchi M, Taylor AW. Immune privilege, T-cell tolerance, and tissue-restricted autoimmunity. Hum Immunol. (1997) 52:138–43. doi: 10.1016/S0198-8859(96)00288-1
59. Cserr HF, Harling-Berg CJ, Knopf PM. Drainage of brain extracellular fluid into blood and deep cervical lymph and its immunological significance. Brain Pathol. (1992) 2:269–76. doi: 10.1111/j.1750-3639.1992.tb00703.x
60. Jochems ACC, Blair GW, Stringer MS, Thrippleton MJ, Clancy U, Chappell FM, et al. Relationship between venules and perivascular spaces in sporadic small vessel diseases. Stroke. (2020) 51:1503–6. doi: 10.1161/STROKEAHA.120.029163
61. Pullicino R, Radon M, Biswas S, Bhojak M, Das K. A review of the current evidence on gadolinium deposition in the brain. Clin Neuroradiol. (2018) 28:159–69. doi: 10.1007/s00062-018-0678-0
62. Taoka T, Naganawa S. Gadolinium-based contrast media, cerebrospinal fluid and the glymphatic system: possible mechanisms for the deposition of gadolinium in the brain. Magn Reson Med Sci. (2018) 17:111–9. doi: 10.2463/mrms.rev.2017-0116
63. Aoki YJ, Wu I, Silva AC, Lynch RM, Koretsky AP. In vivo detection of neuroarchitecture in the rodent brain using manganese-enhanced MRI. Neuroimage. (2004) 22:1046–59. doi: 10.1016/j.neuroimage.2004.03.031
64. Iliff JJ, Lee H, Yu M, Feng T, Logan J, Nedergaard M, et al. Brain-wide pathway for waste clearance captured by contrast-enhanced MRI. J Clin Invest. (2013) 123:1299–309. doi: 10.1172/JCI67677
65. Jost G, Frenzel T, Lohrke J, Lenhard DC, Naganawa S, Pietsch H. Penetration and distribution of gadolinium-based contrast agents into the cerebrospinal fluid in healthy rats: a potential pathway of entry into the brain tissue. Eur Radiol. (2017) 27:2877–85. doi: 10.1007/s00330-016-4654-2
66. Naganawa S, Kawai H, Taoka T, Sone M. Improved HYDROPS: imaging of endolymphatic hydrops after intravenous administration of gadolinium. Magn Reson Med Sci. (2017) 16:357–61. doi: 10.2463/mrms.tn.2016-0126
67. Oner AY, Barutcu B, Aykol S, Tali ET. Intrathecal contrast-enhanced magnetic resonance imaging-related brain signal changes: residual gadolinium deposition? Invest Radiol. (2017) 52:195–7. doi: 10.1097/RLI.0000000000000327
68. Lee H, Xie L, Yu M, Kang H, Feng T, Deane R, et al. The effect of body posture on brain glymphatic transport. J Neurosci. (2015) 35:11034–44. doi: 10.1523/JNEUROSCI.1625-15.2015
69. Weller RO, Massey A, Newman TA, Hutchings M, Kuo YM, Roher AE. Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. Am J Pathol. (1998) 153:725–33. doi: 10.1016/S0002-9440(10)65616-7
Keywords: cerebrospinal fluid, central nervous system, glymphatic clearance, cerebral waste clearance, magnetic resonanace imaging
Citation: Fahmy LM, Chen Y, Xuan S, Haacke EM, Hu J and Jiang Q (2021) All Central Nervous System Neuro- and Vascular-Communication Channels Are Surrounded With Cerebrospinal Fluid. Front. Neurol. 12:614636. doi: 10.3389/fneur.2021.614636
Received: 06 October 2020; Accepted: 29 April 2021;
Published: 17 June 2021.
Edited by:
Achim Gass, University of Heidelberg, GermanyReviewed by:
Nobutaka Hattori, Juntendo University, JapanErik Nicolaas Theodorus Petrus Bakker, University of Amsterdam, Netherlands
Copyright © 2021 Fahmy, Chen, Xuan, Haacke, Hu and Jiang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jiani Hu, jhu@med.wayne.edu; Quan Jiang, qjiang1@hfhs.org
†These authors have contributed equally to this work and share first authorship